July 22, 2026
FDA grants priority review to TALZENNA plus XTANDI application
The FDA accepted a supplemental application and granted priority review for the combination in a metastatic prostate cancer setting.
#Oncology #FDA
View postResearch-based biopharmaceutical medicines and vaccines with a global reach.
pfizer.comLegal name
Pfizer Inc.Founded
1849Founders
Charles Pfizer and Charles Erhart
Headquarters
New York, New York, United States
Listed on
NYSE: PFE
Industry
Biopharmaceuticals
Revenue (2025)
$62.6 billion
Employees (2025)
Approximately 75,000
Manufacturing network
36 plants
Global properties
245
Cousins Charles Pfizer and Charles Erhart founded Pfizer in Brooklyn in 1849. Pfizer Inc. is headquartered in New York and trades on the New York Stock Exchange under PFE.
Pfizer is a research-based global biopharmaceutical company that develops and supplies medicines and vaccines. It reported $62.6 billion in revenue for 2025.
Pfizer reported approximately 75,000 employees and 36 manufacturing plants for 2025. Its official filing identifies manufacturing and research facilities in India, while its careers site recruits for India-based roles.
Chairman and Chief Executive Officer
Executive Vice President and Chief People Experience Officer
Chief Scientific Officer and President, Research and Development
Executive Vice President and Chief Financial Officer
Interview experience
67.5% positive
Interview difficulty
3.08 out of 5
Interview process length
33 days on average, based on 127 reports
Practise behavioral, scientific and role-specific discussions.
Q: Describe a time you recognized someone else's bold idea and moved it forward.
A: Explain how you assessed the idea, gave credit, reduced its risk and helped convert it into a result.
Q: Tell me about a time you led others to focus on the highest-priority work.
A: Show how you made priorities visible, resolved competing demands and protected delivery of the most important outcome.
Q: Tell me about a time you encouraged different viewpoints and helped people speak up.
A: Describe the barrier you noticed, the inclusive method you used and how the additional viewpoint changed the decision.
Q: Describe a time you held others accountable for their commitments.
A: Explain the agreed expectation, your evidence-based conversation and the support or escalation that restored ownership.
Practise behavioral, scientific and role-specific discussions.
Employee-submitted annual range
₹12 lakh to ₹26 lakh per year
20 Salaries submitted
Employee-submitted annual range
₹7 lakh to ₹9 lakh per year
17 Salaries submitted
Employee-submitted annual range
₹7 lakh to ₹14 lakh per year
16 Salaries submitted
Employee-submitted annual range
₹8 lakh to ₹12 lakh per year
15 Salaries submitted
Employee-submitted annual range
₹27 lakh to ₹53 lakh per year
15 Salaries submitted
Employee-submitted annual range
₹3 lakh to ₹6 lakh per year
13 Salaries submitted
Compare employee-submitted India salary estimates by role.
Mumbai, India • Full time
Maharashtra, India • Full time, remote eligible
Mumbai, India • Full time
Chennai, India • Full time
Mumbai, India • Full time
Delhi, India • Full time
Connect your scientific, commercial and operational impact to the role you want.
July 22, 2026
FDA grants priority review to TALZENNA plus XTANDI application
The FDA accepted a supplemental application and granted priority review for the combination in a metastatic prostate cancer setting.
#Oncology #FDA
View postJuly 10, 2026
FDA approves PADCEV plus KEYTRUDA regimen
The FDA approved the regimen for certain patients with muscle-invasive bladder cancer.
#Oncology #Approval
View postJune 24, 2026
Pfizer declares third-quarter 2026 dividend
Pfizer's board declared the company's third-quarter 2026 cash dividend.
#Dividend #Investors
View postJune 24, 2026
FDA approves IBRANCE-based regimen
The FDA approved an IBRANCE-based treatment regimen for a defined HR-positive, HER2-positive metastatic breast cancer population.
#BreastCancer #FDA
View postJune 22, 2026
Pfizer reports Phase 3 lung-cancer study results
Pfizer announced topline Phase 3 results for sigvotatug vedotin in non-small cell lung cancer.
#ClinicalTrial #LungCancer
View postCharles Pfizer and Charles Erhart founded Pfizer in 1849.